For decades, declarations by perturbed relatives that a loved-one’s death was iatrogenic (induced by medical treatment), were often dismissed as anecdotal. Accounts imparted by concerned loved-ones were likely to be rejected, albeit often kindly – yet thrust aside as the demented rantings of a grieving loved-one. Placated with persuasive words, relatives often slink away, suitably … More When Science and Anecdote Collide
Meet Larry, 63. Larry underwent a ‘triple bypass’ operation last Christmas, which involved spending 26 days in the Mater hospital, Dublin. Open heart surgery is known to be a very serious procedure; not least because the sternum (which is opened during surgery) can take up to 12 weeks to heal. Cardiologists acknowledge that Heart surgery is life-changing, both … More Meet Larry..
Yesterday the New York Times reported that a drug named ‘Acthar’, which is used to treat Infantile spasms, used to cost $50 but is now priced at $28,000. Despite questions over its efficacy and drug trials which were suspended, aggressive marketing by Questcor Pharmaceuticals and the support of a ‘Dr. Thrower’ (who also happens to be a paid speaker … More Like taking candy from a baby.
‘RTE Radio 1’ has a Facebook page which proudly states “We’re delighted that RTÉ took home three awards at this year’s GSK Irish Medical Media Awards.” Two of the awards were won for documentaries, one on depression and another for clinical trials involving children. Seriously though? That’s GSK; GlaxoSmithkline! Why is a pharmaceutical company (which … More GlaxoSmithKline awarding the Irish media? No thanks!
So Lundbeck are seeking approval for their latest offering Vortioxetine. This is the drug which Lundbeck director ‘Torsten Madsen’ is referring to in this video. He says ”Some of the studies that we conducted did not have the outcome that we had hoped for, so we speculate that, emm, the reason is due to a too low dosing of 21004″ (Or … More Lundbeck’s Vortioxetine (Lu AA21004) Will the FDA and the EMA approve another ‘killer’ drug?
In March of last year, an Inquest was held into the death of Peter Needham, 40 (a former British Aerospace inspector). Mr Needham was described as a normal, happy, sociable, lovely guy. His dad described him as ‘a beautiful son’. How did Peter (a sociable and popular man) get to the Inquest stage at 40? Very easily! (1) 40-year-old Peter had … More Peter Needham (another victim) and yet another Coroner’s warning.
Lundbeck’s PR department are going into overdrive at the moment. Due to the patents expiring on Celexa and Lexapro, Lundbeck are heavily reliant on finding the next block-buster drug. They seem to think they have found it in LU AA21004. This drug is also known as vortioxetine and according to Lundbeck, 8 out of 10 trials have shown the drug to be … More How safe is Lundbeck’s new drug LU AA21004?